Sandoz filed its opening brief on Friday. Amicus briefs are due on February 17, and the full briefing schedule is available in our prior post.
Big Molecule Watch will provide in depth analysis of the brief soon, so please check back for further updates on this case and other biosimilar-related litigation.
